Health Technology Access Pool (HTAP) by the WHO

By HEOR Staff Writer

February 19, 2024

WHO’s Health Technology Access Pool

The World Health Organization (WHO) has recently announced the Health Technology Access Pool (HTAP). This serves as a successor to the COVID-19 Technology Access Pool (C-TAP). This initiative marks a significant step towards more equitable access to a broad range of health products. The aim is to enhance global health security.

From C-TAP to HTAP: A Journey of Evolution

Launched in May 2020, C-TAP was a collaborative effort between WHO, the Government of Costa Rica, and other partners. This platform was instrumental in providing a forum for technology partners to share intellectual property, knowledge, and data voluntarily. Despite the challenges of establishing a novel mechanism amidst a pandemic, C-TAP managed to secure six transparent, non-exclusive global licences involving 15 technologies that span research and development (R&D) tools, diagnostics, and vaccines.

Building on C-TAP’s Foundation

HTAP is built on the foundation laid by C-TAP but incorporates structural, process, and other changes to attract and support a diverse range of priority technologies more effectively. It aims to promote access to health products that respond to public health priorities, including pandemic preparedness, and are relevant during and outside health emergencies.

Amplifying Public Health Value

HTAP investments will amplify the public health value and increase the attractiveness of licensed technologies to recipient manufacturers. This approach will realise greater market opportunities and financial sustainability. The announcement on the licensing of a rapid diagnostic test platform technology serves as an example of such an approach.

The Future of HTAP: Awaiting Further Details

In the first quarter of 2024, WHO will publish further details on how HTAP will operate and the technologies it will target. Plans are in place to officially launch HTAP in the second quarter of 2024. In the interim, WHO will adopt the principles and approach described above in evaluating opportunities to secure health technologies and expand regional or global production capacity.

Reference url

Recent Posts

Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 2024/25

By João L. Carapinha

October 31, 2025

The CMS Annual Report 2024/25 highlights significant medical schemes affordability challenges in South Africa, where relevant healthcare expenditure per beneficiary surged by 8.70% year-on-year, far outpacing both contribution growth and general inflation. Solvency ratios have declined for three ...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurement Challenges

By João L. Carapinha

October 30, 2025

African Pharmaceutical Growth remains stifled by significant barriers, as highlighted in a recent plenary address at the Conference on Public Health in Africa (CPHIA) 2025 (reported by Health Policy Watch). Dr. Stavros Nicolaou, group senior executive for strategic trade at Aspen Pharmacare and c...
Aligning Medical Schemes with National Health Insurance South Africa
The National Health Insurance initiative in South Africa is advancing toward universal health coverage, and the recent CMS Annual Report 2024/25 highlighted the regulator's pivotal role in supporting this framework by integ...